Mould-active compared with fluconazole prophylaxis to prevent invasive fungal diseases in cancer patients receiving chemotherapy or haematopoietic stem-cell transplantation: a systematic review and meta-analysis of randomised controlled trials.

British Journal of Cancer
M C EthierL Sung

Abstract

Objectives were to compare systemic mould-active vs fluconazole prophylaxis in cancer patients receiving chemotherapy or haematopoietic stem cell transplantation (HSCT). We searched OVID MEDLINE and the Cochrane Central Register of Controlled Trials (1948-August 2011) and EMBASE (1980-August 2011). Randomised controlled trials of mould-active vs fluconazole prophylaxis in cancer or HSCT patients were included. Primary outcome was proven/probable invasive fungal infections (IFI). Analysis was completed by computing relative risks (RRs) using a random-effects model and Mantel-Haenszel method. From 984 reviewed articles, 20 were included in this review. Mould-active compared with fluconazole prophylaxis significantly reduced the number of proven/probable IFI (RR 0.71, 95% CI 0.52 to 0.98; P=0.03). Mould-active prophylaxis also decreased the risk of invasive aspergillosis (IA; RR 0.53, 95% confidence interval (CI) 0.37-0.75; P=0.0004) and IFI-related mortality (RR 0.67, 95% CI 0.47-0.96; P=0.03) but is also associated with an increased risk of adverse events (AEs) leading to antifungal discontinuation (RR 1.95, 95% CI 1.24-3.07; P=0.004). There was no decrease in overall mortality (RR 1.0; 95% CI 0.88-1.13; P=0.96). Mould-active co...Continue Reading

References

Nov 24, 1999·Journal of Clinical Pathology·P C HuijgensA R Jonkhoff
Jun 14, 2000·BMJ : British Medical Journal·A J SuttonD R Jones
Dec 4, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S AsciogluUNKNOWN Mycoses Study Group of the National Institute of Allergy and Infectious Diseases
Dec 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Axel GlasmacherIngo G H Schmidt-Wolf
Nov 17, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jo-Anne H van BurikUNKNOWN National Institute of Allergy and Infectious Diseases Mycoses Study Group
May 24, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kieren A MarrWendy Leisenring
Jan 26, 2007·The New England Journal of Medicine·Andrew J UllmannSimon Durrant
Jan 26, 2007·The New England Journal of Medicine·Oliver A CornelyDavid Angulo-Gonzalez
Oct 3, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eyal RobenshtokMical Paul
Jan 8, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Thomas J WalshUNKNOWN Infectious Diseases Society of America
May 9, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ben De PauwUNKNOWN National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Jul 30, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Thomas LehrnbecherAndreas H Groll
Nov 29, 2008·International Journal of Hematology·Yasushi HiramatsuUNKNOWN West-Japan Hematology and Oncology Group (West-JHOG)
Jul 23, 2009·Annals of Internal Medicine·David MoherUNKNOWN PRISMA Group
Jul 28, 2010·Bone Marrow Transplantation·J MaertensUNKNOWN Third European Conference on Infections in Leukemia
Oct 26, 2010·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·George Dranitsaris, Haytham Khoury
Jan 6, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Alison G Freifeld Infectious Diseases Society of Americaa

❮ Previous
Next ❯

Citations

Feb 18, 2016·Expert Opinion on Emerging Drugs·John R Perfect
Feb 14, 2015·Expert Opinion on Pharmacotherapy·Zoi-Dorothea PanaEmmanuel Roilides
Jun 3, 2016·Pediatrics in Review·Jennifer Lighter-FisherLiana M Klejmont
Mar 21, 2017·Journal de mycologie médicale·N LequilliecJ-P Gangneux
Jul 24, 2018·Expert Review of Anti-infective Therapy·Alessandro Busca, Livio Pagano
Jun 6, 2018·Antimicrobial Agents and Chemotherapy·Cho-Hao LeeJung-Chung Lin
Dec 21, 2012·Pediatric Blood & Cancer·Lillian SungUNKNOWN Children's Oncology Group Cancer Control and Supportive Care Committee
Sep 20, 2011·Bone Marrow Transplantation·O MarchettiUNKNOWN European Conference on Infections in Leukemia (ECIL) Laboratory Working Groups
Oct 24, 2017·Bone Marrow Transplantation·S M RubinsteinG Satyanarayana
Dec 10, 2019·Current Opinion in Pediatrics·Caitlin W Elgarten, Richard Aplenc
Jan 9, 2020·Expert Opinion on Pharmacotherapy·Nira Arad-CohenYael Shachor-Meyouhas
Mar 12, 2020·British Journal of Haematology·William R Otto, Abby M Green
Nov 23, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ghady HaidarPalash Samanta
Sep 19, 2015·Current Opinion in Infectious Diseases·Thomas Lehrnbecher
May 5, 2018·Case Reports in Hematology·Mehmet BaysalMuzaffer Demir
Jun 22, 2019·The Journal of Antimicrobial Chemotherapy·Rosemary BarnesJohan Maertens
Mar 16, 2017·British Journal of Haematology·Kamille A WestSameer S Kadri
Jun 23, 2019·Current Hematologic Malignancy Reports·Wei JiangEmily Blyth
May 17, 2019·The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG·Annie BuiTiffany Simms-Waldrip
Jul 31, 2018·Future Science OA·Livio Pagano, Susan Mayor
Jul 2, 2020·Current Hematologic Malignancy Reports·Joselle Cook, Mark Litzow
Sep 12, 2020·Environmental Science and Pollution Research International·Hailemariam Abrha AssressTitus A M Msagati
Nov 20, 2020·European Journal of Haematology·Vilhjálmur SteingrímssonSigurdur Y Kristinsson
Oct 16, 2020·Haematologica·Noa Granot, Rainer Storb
Apr 29, 2021·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Leah B HerityMay T Aziz

❮ Previous
Next ❯

Software Mentioned

SAS
Review Manager
Web of Science
PC

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.